Stock Price Quote

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE650.503.85 (+0.6 %)
PREV CLOSE ( ) 646.65
OPEN PRICE ( ) 645.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12081
TODAY'S LOW / HIGH ( )638.65 658.00
52 WK LOW / HIGH ( )473 804.3
NSE650.154.45 (+0.69 %)
PREV CLOSE( ) 645.70
OPEN PRICE ( ) 643.90
BID PRICE (QTY) 650.15 (28)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 93332
TODAY'S LOW / HIGH( ) 638.60 653.75
52 WK LOW / HIGH ( )472.55 804.65
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1998
Management Info
B S Ajai Kumar - Chairman - Managing Director
Registered Office

Address H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama Nagar,
Bengaluru,
Karnataka-560027

Phone 080 - 33669999

Email info@hcgoncology.com

Website www.hcgoncology.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

01Dec HealthCare Global Enterprises informs
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
13Nov Healthcare Global Enterprises gets nod
Healthcare Global Enterprises has received approval to invest up to Rs 1..
13Nov Healthcare Global Enterprises gains on
Healthcare Global Enterprises is currently trading at Rs. 749.65, up by..
04Nov HealthCare Global Enterprises informs
HealthCare Global Enterprises has informed that it enclsoed disclosure u..
17Oct HealthCare Global Enterprises informs
HealthCare Global Enterprises has certified that the details of securiti..

Financials

in Millions
QTR Sep 25 ANNUAL 25
Net Profit107.835.299999999999
Gross Profit 146 195.799999999999
Operating Profit 661.22499.3
Net Sales 3458.412804.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Krsnaa Diagnostics (BSE)
peergroup  722.15 (3.06%)
M.Cap ( in Cr)2342.56
Metropolis Health. (BSE)
peergroup  1917.00 (0.60%)
M.Cap ( in Cr)9936.18
NG Industries (BSE)
peergroup  144.90 (6.39%)
M.Cap ( in Cr)48.55
Thyrocare Tech. (BSE)
peergroup  475.30 (1.79%)
M.Cap ( in Cr)7564.96
Nephrocare Health Se (BSE)
peergroup  513.20 (1.64%)
M.Cap ( in Cr)5149.49

Shareholding Pattern

PROMOTERS 63.78%
MUTUAL FUNDS/UTI 14.63%
NON-INSTITUTION 14.27%
FI/BANKS/INSURANCE 0.61%
GOVERNMENT 0%
FII 0%

About Healthcare Global Enterprises Ltd.

Healthcare Global Enterprises Ltd. was incorporated in the year 1998. Its today's share price is 650.5. Its current market capitalisation stands at Rs 9172.55 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12765.21 Cr and Total Income of Rs.13151.02 Cr. The company's management includes Bijou Kurien, Rajiv Mailwal, Pradip Kanakia, Raj Raghavan, Geeta Mathur, Simrun Mehta, Akshay Tanna, Anjali Ajaikumar, Manish Mattoo, B S Ajai Kumar, Sunu Manuel.

It is listed on the BSE with a BSE Code of 539787 , NSE with an NSE Symbol of HCG and ISIN of INE075I01017. It's Registered office is at H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama NagarBengaluru-560027, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.